<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38339115</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19-A Narrative Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1837</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25031837</ELocationID><Abstract><AbstractText>Arterial hypertension is one of the most common and significant cardiovascular risk factors. There are many well-known and identified risk factors for its development. In recent times, there has been growing concern about the potential impact of COVID-19 on the cardiovascular system and its relation to arterial hypertension. Various theories have been developed that suggest a connection between COVID-19 and elevated blood pressure. However, the precise link between SARS-CoV-2 infection and the long-term risk of developing hypertension remains insufficiently explored. Therefore, the primary objective of our study was to investigate the influence of COVID-19 infection on blood pressure elevation and the subsequent risk of developing arterial hypertension over an extended period. To accomplish this, we conducted a thorough search review of relevant papers in the PubMed and SCOPUS databases up to 3 September 2023. Our analysis encompassed a total of 30 eligible articles. Out of the 30 papers we reviewed, 19 of them provided substantial evidence showing a heightened risk of developing arterial hypertension following COVID-19 infection. Eight of the studies showed that blood pressure values increased after the infection, while three of the qualified studies did not report any notable impact of COVID-19 on blood pressure levels. The precise mechanism behind the development of hypertension after COVID-19 remains unclear, but it is suggested that endothelial injury and dysfunction of the renin-angiotensin-aldosterone system may be contributory. Additionally, changes in blood pressure following COVID-19 infection could be linked to lifestyle alterations that often occur alongside the illness. Our findings emphasize the pressing requirement for thorough research into the relationship between COVID-19 and hypertension. These insights are essential for the development of effective prevention and management approaches for individuals who have experienced COVID-19 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bielecka</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9753-6252</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sielatycki</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietraszko</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zapora-Kurel</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zbroch</LastName><ForeName>Edyta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0121-3254</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">post covid</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>14</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38339115</ArticleId><ArticleId IdType="pmc">PMC10856065</ArticleId><ArticleId IdType="doi">10.3390/ijms25031837</ArticleId><ArticleId IdType="pii">ijms25031837</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al Ghorani H., G&#xf6;tzinger F., B&#xf6;hm M., Mahfoud F. Arterial hypertension&#x2014;Clinical trials update 2021. Nutr. Metab. Cardiovasc. Dis. 2022;32:21&#x2013;31. doi: 10.1016/j.numecd.2021.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2021.09.007</ArticleId><ArticleId IdType="pmc">PMC8444354</ArticleId><ArticleId IdType="pubmed">34690044</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelton P.K., Carey R.M., Aronow W.S., Casey D.E., Jr., Collins K.J., Himmelfarb C.D., DePalma S.M., Gidding S., Jamerson K.A., Jones D.W., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13&#x2013;e115. doi: 10.1161/hyp.0000000000000065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hyp.0000000000000065</ArticleId><ArticleId IdType="pubmed">29133356</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunstr&#xf6;m M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Agabiti-Rosei E., Algharably E.A.E., Azizi M., Benetos A., et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J. Hypertens. 2023;41:1874&#x2013;2071.</Citation><ArticleIdList><ArticleId IdType="pubmed">37345492</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger T., Borghi C., Charchar F., Khan N.A., Poulter N.R., Prabhakaran D., Ramirez A., Schlaich M., Stergiou G.S., Tomaszewski M., et al. 2020 International Society of Hypertension global hypertension practice guidelines. J. Hypertens. 2020;38:982&#x2013;1004. doi: 10.1097/HJH.0000000000002453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002453</ArticleId><ArticleId IdType="pubmed">32371787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension in Adults: Diagnosis and Management  National Institute for Health and Care Excellence (NICE)  [(accessed on 23 October 2020)].  Available online:  http://www.nice.org.uk/guidance/ng136.</Citation></Reference><Reference><Citation>Forman J.P., Stampfer M.J., Curhan G.C. Diet and Lifestyle Risk Factors Associated with Incident Hypertension in Women. JAMA. 2009;302:401&#x2013;411. doi: 10.1001/jama.2009.1060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1060</ArticleId><ArticleId IdType="pmc">PMC2803081</ArticleId><ArticleId IdType="pubmed">19622819</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonne-Holm S., Sorensen T.I., Jensen G., Schnohr P. Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men. BMJ. 1989;299:767&#x2013;770. doi: 10.1136/bmj.299.6702.767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.299.6702.767</ArticleId><ArticleId IdType="pmc">PMC1837623</ArticleId><ArticleId IdType="pubmed">2508915</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapsomaniki E., Timmis A., George J., Pujades-Rodriguez M., Shah A.D., Denaxas S., White I.R., Caulfield M.J., Deanfield J.E., Smeeth L., et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383:1899&#x2013;1911. doi: 10.1016/S0140-6736(14)60685-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60685-1</ArticleId><ArticleId IdType="pmc">PMC4042017</ArticleId><ArticleId IdType="pubmed">24881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannel W.B. Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA. 1996;275:1571&#x2013;1576. doi: 10.1001/jama.1996.03530440051036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1996.03530440051036</ArticleId><ArticleId IdType="pubmed">8622248</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Miller N.H., Hubbard V.S., Lee I.M., Lichtenstein A.H., Loria C.M., Millen B.E., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014;63:2960. doi: 10.1016/j.jacc.2013.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.11.003</ArticleId><ArticleId IdType="pubmed">24239922</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Living with COVID-19. 2020.  [(accessed on 27 January 2024)].  Available online:  https://evidence.nihr.ac.uk/themedreview/living-with-covid19/</Citation></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 Condition (Long COVID)  [(accessed on 27 January 2024)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Munblit D., O&#x2019;Hara M.E., Akrami A., Perego E., Olliaro P., Needham D.M. Long COVID: Aiming for a consensus. Lancet Respir. Med. 2022;10:632&#x2013;634. doi: 10.1016/S2213-2600(22)00135-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00135-7</ArticleId><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizgar P., Yazdankhah N., Rzepka A.M., Chung K.Y.C., Ali I., Fur R.L.F., Russell V., Cheung A.M. Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes. Can. J. Cardiol. 2023;39:726&#x2013;740. doi: 10.1016/j.cjca.2023.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.01.031</ArticleId><ArticleId IdType="pmc">PMC9901229</ArticleId><ArticleId IdType="pubmed">36754119</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., Suarez M.D., Shelly S., Lamotte G.J., Sandroni P., Benarroch E.E., Berini S.E., Cutsforth-Gregory J.K., et al. Autonomic dysfunction following COVID-19 infection: An early experience. Clin. Auton. Res. 2021;31:385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Y.L., Leong H.N., Hsu L.Y., Tan T.T., Kurup A., Fook-Chong S., Tan B.H. Autonomic dysfunction in recovered severe acute respiratory syndrome patients. Can. J. Neurol. Sci. 2005;32:264. doi: 10.1017/S0317167100004108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100004108</ArticleId><ArticleId IdType="pubmed">16018168</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S.J., Feigen C.M., Vazquez J.P., Kobets A.J., Altschul D.J. Neurological Sequelae of COVID-19. J. Integr. Neurosci. 2022;21:77. doi: 10.31083/j.jin2103077.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor&#x2019;s page series. J. Thromb. Thrombolysis. 2021;52:692&#x2013;707. doi: 10.1007/s11239-021-02549-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02549-6</ArticleId><ArticleId IdType="pmc">PMC8367772</ArticleId><ArticleId IdType="pubmed">34403043</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques K.C., Silva C.C., Trindade S.d.S., Santos M.C.d.S., Rocha R.S.B., Vasconcelos P.F.d.C., Quaresma J.A.S., Falc&#xe3;o L.F.M. Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients with Long COVID. Front. Cardiovasc. Med. 2022;9:862001. doi: 10.3389/fcvm.2022.862001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.862001</ArticleId><ArticleId IdType="pmc">PMC9098798</ArticleId><ArticleId IdType="pubmed">35571200</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom E.F., Nath A., Power C. Acute and chronic neurological disorders in COVID-19: Potential mechanisms of disease. Brain. 2021;144:3576&#x2013;3588. doi: 10.1093/brain/awab302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman B.P., Khoury J.A., Blair J.E., Grill M.F. COVID-19 Dysautonomia. Front. Neurol. 2021;12:624968. doi: 10.3389/fneur.2021.624968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. 2021;21:63&#x2013;67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Jolkkoken J., Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses. Neurosci. Biobehav. Rev. 2020;11:184&#x2013;193. doi: 10.1016/j.neubiorev.2020.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7571477</ArticleId><ArticleId IdType="pubmed">33091416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstr&#xf6;m M., von Seth M., Frithiof R. Hyperreninemia and low total body water may contribute to acute kidney injury in COVID-19 patients in intensive care. J. Hypertens. 2020;38:1613&#x2013;1614. doi: 10.1097/HJH.0000000000002531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002531</ArticleId><ArticleId IdType="pmc">PMC7282406</ArticleId><ArticleId IdType="pubmed">32472780</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed S., Tadic M., Larsen T.H., Grassi G., Mancia G. Coronavirus disease 2019 and cardiovascular complications: Focused clinical review. J. Hypertens. 2021;39:1282&#x2013;1292. doi: 10.1097/HJH.0000000000002819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002819</ArticleId><ArticleId IdType="pmc">PMC9904438</ArticleId><ArticleId IdType="pubmed">33687179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Yao S., Sun G., Yu S., Sun Z., Zheng L., Xu C., Li J., Sun Y. Total and abdominal obesity among rural Chinese women and the association with hypertension. Nutrition. 2012;28:46&#x2013;52. doi: 10.1016/j.nut.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2011.02.004</ArticleId><ArticleId IdType="pubmed">21621392</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Itoh H. Hypertension as a Metabolic Disorder and the Novel Role of the Gut. Curr. Hypertens. Rep. 2019;21:63. doi: 10.1007/s11906-019-0964-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-019-0964-5</ArticleId><ArticleId IdType="pmc">PMC6591187</ArticleId><ArticleId IdType="pubmed">31236708</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhamad S.-A., Ugusman A., Kumar J., Skiba D., Hamid A.A., Aminuddin A. COVID-19 and Hypertension: The What, the Why, and the How. Front. Physiol. 2021;12:665064. doi: 10.3389/fphys.2021.665064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.665064</ArticleId><ArticleId IdType="pmc">PMC8126692</ArticleId><ArticleId IdType="pubmed">34012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Parrella P., Formisano R., Perrotta G., D&#x2019;anna S.E., Mosella M., Papa A., Maniscalco M. Cardiopulmonary Exercise Performance and Endothelial Function in Convalescent COVID-19 Patients. J. Clin. Med. 2022;11:1452. doi: 10.3390/jcm11051452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051452</ArticleId><ArticleId IdType="pmc">PMC8911200</ArticleId><ArticleId IdType="pubmed">35268542</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., Bahloul A., Kallel N., Moussa N., Touil I., et al. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front. Cardiovasc. Med. 2021;8:745758. doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Konukoglu D., Uzun H. Endothelial dysfunction and hypertension. Adv. Exp. Med. Biol. 2017;956:511&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">28035582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogier van der Velde A., Meijers W.C., de Boer R.A. Chapter 3.7.1&#x2014;Cardiovascular biomarkers: Translational aspects of hypertension, atherosclerosis, and heart failure in drug development. In: Wehling M., editor. Principles of Translational Science in Medicine. 2nd ed. Academic Press; Boston, MA, USA: 2015. pp. 167&#x2013;183.</Citation></Reference><Reference><Citation>Liberati A., Altman D.G., Tetzlaff J., Mulrow C., G&#xf8;tzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009;62:e1&#x2013;e34. doi: 10.1016/j.jclinepi.2009.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.006</ArticleId><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Q., Wang F., Yang Y., Hu G., Guo S., Zhang Q., Bryant A., Zhang L., Kurts C., Wei L., et al. Health Issues and Immunological Assessment Related to Wuhan&#x2019;s COVID-19 Survivors: A Multicenter Follow-Up Study. Front. Med. 2021;8:617689. doi: 10.3389/fmed.2021.617689.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.617689</ArticleId><ArticleId IdType="pmc">PMC8138053</ArticleId><ArticleId IdType="pubmed">34026775</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y.F., Liu T., Yu J.N., Xu X.R., Zahid K.R., Wei Y.C., Wang X.H., Zhou F.L. Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors. J. Intern. Med. 2021;290:444&#x2013;450. doi: 10.1111/joim.13284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13284</ArticleId><ArticleId IdType="pmc">PMC8242565</ArticleId><ArticleId IdType="pubmed">33904618</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L., Meli G., Poletti F., Rostagno R., Moglia R., Cantone M., Esposito M., Scianguetta C., Domenicale B., Di Pasquale F., et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: Does remdesivir have a protective effect? QJM Int. J. Med. 2021;114:865&#x2013;871. doi: 10.1093/qjmed/hcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zcan S., &#x130;nce O., G&#xfc;ner A., Katkat F., D&#xf6;nmez E., Tu&#x11f;rul S., &#x15e;ahin &#x130;., Okuyan E., Kay&#x131;k&#xe7;&#x131;o&#x11f;lu M. Long-Term Clinical Consequences of Patients Hospitalized for COVID-19 Infection. Anatol. J. Cardiol. 2022;26:305&#x2013;315. doi: 10.5152/AnatolJCardiol.2022.924.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/AnatolJCardiol.2022.924</ArticleId><ArticleId IdType="pmc">PMC9366384</ArticleId><ArticleId IdType="pubmed">35435842</ArticleId></ArticleIdList></Reference><Reference><Citation>Akpek M. Does COVID-19 Cause Hypertension? Angiology. 2022;73:682&#x2013;687. doi: 10.1177/00033197211053903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197211053903</ArticleId><ArticleId IdType="pmc">PMC9260192</ArticleId><ArticleId IdType="pubmed">34889662</ArticleId></ArticleIdList></Reference><Reference><Citation>Delali&#x107; &#x110;., Jug J., Prka&#x10d;in I. Arterial hypertension following COVID-19: A retrospective study of patients in a Central European tertiary care center. Acta Clin. Croat. 2022;61:23&#x2013;26. doi: 10.20471/acc.2022.61.s1.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.20471/acc.2022.61.s1.03</ArticleId><ArticleId IdType="pmc">PMC9536154</ArticleId><ArticleId IdType="pubmed">36304797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogungbe O., Gilotra N.A., Davidson P.M., Farley J.E., Himmelfarb C.R.D., Post W.S., Commodore-Mensah Y. Cardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults: Cross-sectional study. Open Heart. 2022;9:e002084. doi: 10.1136/openhrt-2022-002084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2022-002084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Ortega M., Ponce-Rosas E.R., Mu&#xf1;iz-Salinas D.A., Rodr&#xed;guez-Mendoza O., Ch&#xe1;vez P.N., S&#xe1;nchez-Pozos V., D&#xe1;vila-Mendoza R., Barrell A.E. Cognitive dysfunction, diabetes mellitus 2 and arterial hypertension: Sequelae up to one year of COVID-19. Travel. Med. Infect. Dis. 2023;52:102553. doi: 10.1016/j.tmaid.2023.102553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2023.102553</ArticleId><ArticleId IdType="pmc">PMC9981335</ArticleId><ArticleId IdType="pubmed">36805019</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas P., Joshi D., Sharma V., Parmar M., Vadodariya J., Patel K., Modi G. Incidence and predictors of development of new onset hypertension post COVID-19 disease. Indian. Heart J. 2023;75:347&#x2013;351. doi: 10.1016/j.ihj.2023.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2023.06.002</ArticleId><ArticleId IdType="pmc">PMC10265930</ArticleId><ArticleId IdType="pubmed">37328135</ArticleId></ArticleIdList></Reference><Reference><Citation>Abumayyaleh M., Gil I.J.N., Viana-Llamas M.C., Roubin S.R., Romero R., Alfonso-Rodr&#xed;guez E., Uribarri A., Feltes G., Becerra-Mu&#xf1;oz V.M., Santoro F., et al. Post-COVID-19 syndrome and diabetes mellitus: A propensity-matched analysis of the International HOPE-II COVID-19 Registry. Front. Endocrinol. 2023;14:1167087. doi: 10.3389/fendo.2023.1167087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1167087</ArticleId><ArticleId IdType="pmc">PMC10227507</ArticleId><ArticleId IdType="pubmed">37260447</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz M.M., Arias &#xc1;., Mata-V&#xe1;zquez E., Mart&#xed;n-Toledano M., L&#xf3;pez-Larramona G., Ruiz-Chicote A.M., Nieto-Sandoval B., Lucendo A.J. Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. J. Clin. Med. 2021;10:2945. doi: 10.3390/jcm10132945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.G., Dagliati A., Abad Z.S.H., Xiong X., Bonzel C.-L., Xia Z., Tan B.W.Q., Avillach P., Brat G.A., Hong C., et al. International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit. Med. 2022;5:81. doi: 10.1038/s41746-022-00623-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-022-00623-8</ArticleId><ArticleId IdType="pmc">PMC9242995</ArticleId><ArticleId IdType="pubmed">35768548</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K., Ren S., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Guo Y., Lipsitch M., Daugherty S.E. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennifer K., Shirley S.B.D., Avi P., Daniella R.-C., Naama S.S., Anat E.Z., Miri M.-R. Post-acute sequelae of COVID-19 infection. Prev. Med. Rep. 2023;31:102097. doi: 10.1016/j.pmedr.2022.102097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmedr.2022.102097</ArticleId><ArticleId IdType="pmc">PMC9767882</ArticleId><ArticleId IdType="pubmed">36567743</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisler A., Stirrup O., Pisarev H., Kalda R., Meister T., Suija K., Kolde R., Piirsoo M., Uusk&#xfc;la A. Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study. PLoS ONE. 2022;17:e0278057. doi: 10.1371/journal.pone.0278057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278057</ArticleId><ArticleId IdType="pmc">PMC9683565</ArticleId><ArticleId IdType="pubmed">36417409</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfadda A.A., Rafiullah M., Alkhowaiter M., Alotaibi N., Alzahrani M., Binkhamis K., Siddiqui K., Youssef A., Altalhi H., Almaghlouth I., et al. Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation. Front. Med. 2022;9:1067082. doi: 10.3389/fmed.2022.1067082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1067082</ArticleId><ArticleId IdType="pmc">PMC9763306</ArticleId><ArticleId IdType="pubmed">36561720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ternushchak T.M., Tovt-Korshynska M.I., Varvarynets A.V. Ambulatory blood pressure variability in young adults with long-COVID syndrome. Wiadomo&#x15b;ci Lek. Mon. J. 2022;75:2481&#x2013;2485. doi: 10.36740/WLek202210131.</Citation><ArticleIdList><ArticleId IdType="doi">10.36740/WLek202210131</ArticleId><ArticleId IdType="pubmed">36472284</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Conte C., Lanzani C., Benedetti F., Roveri L., Mazza M.G., Brioni E., Giacalone G., Canti V., Sofia V., et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS ONE. 2020;15:e0239570. doi: 10.1371/journal.pone.0239570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239570</ArticleId><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni S.E., Tonon C.R., Gatto M., Mota G.A., Okoshi M.P. Post-COVID-19 syndrome: Cardiovascular manifestations. Int. J. Cardiol. 2022;369:80&#x2013;81. doi: 10.1016/j.ijcard.2022.08.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.08.054</ArticleId><ArticleId IdType="pmc">PMC9434909</ArticleId><ArticleId IdType="pubmed">36058345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameil M.A., Marzouk R.E., Elsebaie A.H., Rozaik S.E. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt. Liver J. 2021;11:74. doi: 10.1186/s43066-021-00144-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43066-021-00144-1</ArticleId><ArticleId IdType="pmc">PMC8435147</ArticleId><ArticleId IdType="pubmed">34777873</ArticleId></ArticleIdList></Reference><Reference><Citation>Salo&#x148; A., Neshev R., Tera&#x17e; K., &#x160;imuni&#x10d; B., Peskar M., Maru&#x161;i&#x10d; U., Pi&#x161;ot S., &#x160;losar L., Gasparini M., Pi&#x161;ot R., et al. A pilot study: Exploring the influence of COVID-19 on cardiovascular physiology and retinal microcirculation. Microvasc. Res. 2023;150:104588. doi: 10.1016/j.mvr.2023.104588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2023.104588</ArticleId><ArticleId IdType="pubmed">37468091</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandadeva D., Skow R.J., Stephens B.Y., Grotle A.K., Georgoudiou S., Barshikar S., Seo Y., Fadel P.J. Cardiovascular and cerebral vascular health in females with postacute sequelae of COVID-19. Am. J. Physiol. Heart Circ. Physiol. 2023;324:713&#x2013;720. doi: 10.1152/ajpheart.00018.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00018.2023</ArticleId><ArticleId IdType="pmc">PMC10151056</ArticleId><ArticleId IdType="pubmed">37000609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud Z., East L., Gleva M., Woodard P.K., Lavine K., Verma A.K. Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2. Int. J. Cardiol. 2022;366:35&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278009</ArticleId><ArticleId IdType="pubmed">35842003</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandadeva D., Skow R.J., Grotle A.-K., Stephens B.Y., Young B.E., Fadel P.J. Impact of COVID-19 on ambulatory blood pressure in young adults: A cross-sectional analysis investigating time since diagnosis. J. Appl. Physiol. 2022;133:183&#x2013;190. doi: 10.1152/japplphysiol.00216.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00216.2022</ArticleId><ArticleId IdType="pmc">PMC9291414</ArticleId><ArticleId IdType="pubmed">35708703</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sluijs K.M., Bakker E.A., Schuijt T.J., Joseph J., Kavousi M., Geersing G.-J., Rutten F.H., Hartman Y.A.W., Thijssen D.H.J., Eijsvogels T.M.H. Long-term cardiovascular health status and physical functioning of nonhospitalized patients with COVID-19 compared with non-COVID-19 controls. Am. J. Physiol. Circ. Physiol. 2023;324:H47&#x2013;H56. doi: 10.1152/ajpheart.00335.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00335.2022</ArticleId><ArticleId IdType="pmc">PMC9870581</ArticleId><ArticleId IdType="pubmed">36459448</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah N.P., Clare R.M., Chiswell K., Navar A.M., Shah B.R., Peterson E.D. Trends of blood pressure control in the U.S. during the COVID-19 pandemic. Am. Heart J. 2022;247:15&#x2013;23. doi: 10.1016/j.ahj.2021.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2021.11.017</ArticleId><ArticleId IdType="pmc">PMC8662834</ArticleId><ArticleId IdType="pubmed">34902314</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojciechowska W., Rajzer M., Weber T., Prejbisz A., Dobrowolski P., Ostrowska A., Bilo G., Mancia G., Kreutz R., Januszewicz A. Ambulatory blood pressure monitoring in treated patients with hypertension in the COVID-19 pandemic&#x2014;The study of European society of hypertension (ESH ABPM COVID-19 study) Blood Press. 2023;32:2161998. doi: 10.1080/08037051.2022.2161998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08037051.2022.2161998</ArticleId><ArticleId IdType="pubmed">36694963</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcocer-D&#xed;az-Barreiro L., Cossio-Aranda J., Verdejo-Paris J., Odin-de-Los-R&#xed;os M., Galv&#xe1;n-Oseguera H., &#xc1;lvarez-L&#xf3;pez H., Alcocer-Gamba M.A. COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship. Arch. Cardiol. Mex. 2020;90:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">32523145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario C.M., Chappell M.C., Tallant E.A., Brosnihan K.B., Diz D.I. Counterregulatory Actions of Angiotensin-(1-7) Hypertension. 1997;30:535&#x2013;541. doi: 10.1161/01.HYP.30.3.535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.30.3.535</ArticleId><ArticleId IdType="pubmed">9322978</ArticleId></ArticleIdList></Reference><Reference><Citation>Roks A.J., van Geel P.P., Pinto Y.M., Buikema H., Henning R.H., de Zeeuw D., van Gilst W.H. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension. 1999;34:296&#x2013;301. doi: 10.1161/01.HYP.34.2.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.34.2.296</ArticleId><ArticleId IdType="pubmed">10454457</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto K., Ohishi M., Katsuya T., Ito N., Ikushima M., Kaibe M., Tatara Y., Shiota A., Sugano S., Takeda S., et al. Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II. Hypertension. 2006;47:718&#x2013;726. doi: 10.1161/01.HYP.0000205833.89478.5b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000205833.89478.5b</ArticleId><ArticleId IdType="pubmed">16505206</ArticleId></ArticleIdList></Reference><Reference><Citation>Freel E.M., Connell J.M. Mechanisms of hypertension: The expanding role of aldosterone. J. Am. Soc. Nephrol. 2004;15:1993&#x2013;2001. doi: 10.1097/01.ASN.0000132473.50966.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000132473.50966.14</ArticleId><ArticleId IdType="pmc">PMC1283142</ArticleId><ArticleId IdType="pubmed">15284285</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.A.S., Sampaio W.O., Alzamora A.C., Motta-Santos D., Alenina N., Bader M., Campagnole-Santos M.J. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7) Physiol. Rev. 2018;98:505&#x2013;553. doi: 10.1152/physrev.00023.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00023.2016</ArticleId><ArticleId IdType="pmc">PMC7203574</ArticleId><ArticleId IdType="pubmed">29351514</ArticleId></ArticleIdList></Reference><Reference><Citation>de Queiroz T.M., Lakkappa N., Lazartigues E. ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension. Front. Pharmacol. 2020;11:1154. doi: 10.3389/fphar.2020.01154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01154</ArticleId><ArticleId IdType="pmc">PMC7403492</ArticleId><ArticleId IdType="pubmed">32848763</ArticleId></ArticleIdList></Reference><Reference><Citation>Salom&#xe3;o R., Assis V., de Sousa Neto I.V., Petriz B., Babault N., Durigan J.L.Q., de C&#xe1;ssia Marqueti R. Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions. Biology. 2023;12:843. doi: 10.3390/biology12060843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12060843</ArticleId><ArticleId IdType="pmc">PMC10295079</ArticleId><ArticleId IdType="pubmed">37372128</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy V., Gjymishka A., Jarajapu Y.P., Qi Y., Afzal A., Rigatto K., Ferreira A.J., Fraga-Silva R.A., Kearns P., Douglas J.Y., et al. Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models. Am. J. Respir. Crit. Care Med. 2013;187:648&#x2013;657. doi: 10.1164/rccm.201205-0880OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201205-0880OC</ArticleId><ArticleId IdType="pmc">PMC3733435</ArticleId><ArticleId IdType="pubmed">23370913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A.J., Shenoy V., Yamazato Y., Sriramula S., Francis J., Yuan L., Castellano R.K., Ostrov D.A., Oh S.P., Katovich M.J., et al. Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 2009;179:1048&#x2013;1054. doi: 10.1164/rccm.200811-1678OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200811-1678OC</ArticleId><ArticleId IdType="pmc">PMC2689912</ArticleId><ArticleId IdType="pubmed">19246717</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., et al. Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase. J. Biol. Chem. 2002;277:14838&#x2013;14843. doi: 10.1074/jbc.M200581200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200581200</ArticleId><ArticleId IdType="pubmed">11815627</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Xia H., Santos R.A., Speth R., Lazartigues E. Angiotensin-converting enzyme 2: A new target for neurogenic hypertension. Exp. Physiol. 2010;95:601&#x2013;606. doi: 10.1113/expphysiol.2009.047407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2009.047407</ArticleId><ArticleId IdType="pmc">PMC2858233</ArticleId><ArticleId IdType="pubmed">19923158</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurley S.B., Allred A., Le T.H., Griffiths R., Mao L., Philip N., Haystead T.A., Donoghue M., Breitbart R.E., Acton S.L., et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Investig. 2006;116:2218&#x2013;2225. doi: 10.1172/JCI16980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI16980</ArticleId><ArticleId IdType="pmc">PMC1518789</ArticleId><ArticleId IdType="pubmed">16878172</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka I., Bertram S., Herzog P., Pfefferle S., Steffen I., Muench M.O., Simmons G., Hofmann H., Kuri T., Weber F., et al. Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63. J. Virol. 2010;84:1198&#x2013;1205. doi: 10.1128/JVI.01248-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01248-09</ArticleId><ArticleId IdType="pmc">PMC2798380</ArticleId><ArticleId IdType="pubmed">19864379</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes J.M., Grimes K.V. p38 MAPK inhibition: A promising therapeutic approach for COVID-19. J. Mol. Cell Cardiol. 2020;144:63&#x2013;65. doi: 10.1016/j.yjmcc.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7228886</ArticleId><ArticleId IdType="pubmed">32422320</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D., Italia L., Adamo M., Inciardi R.M., Lombardi C.M., Solomon S.D., Metra M. COVID-19 and heart failure: From infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur. J. Heart Fail. 2020;22:957&#x2013;966. doi: 10.1002/ejhf.1871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1871</ArticleId><ArticleId IdType="pmc">PMC7273093</ArticleId><ArticleId IdType="pubmed">32412156</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Pfeffer M.A. Plasma angiotensin-converting enzyme 2: Novel biomarker in heart failure with implications for COVID-19. Eur. Heart J. 2020;41:1818&#x2013;1820. doi: 10.1093/eurheartj/ehaa414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa414</ArticleId><ArticleId IdType="pmc">PMC7224688</ArticleId><ArticleId IdType="pubmed">32388547</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450&#x2013;454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.-L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Gui M., Wang X., Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLOS Pathog. 2018;14:e1007236. doi: 10.1371/journal.ppat.1007236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007236</ArticleId><ArticleId IdType="pmc">PMC6107290</ArticleId><ArticleId IdType="pubmed">30102747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Li W., Farzan M., Harrison S. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309:1864&#x2013;1868. doi: 10.1126/science.1116480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1116480</ArticleId><ArticleId IdType="pubmed">16166518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D., et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H.P., Look D.C., Tan P., Shi L., Hickey M., Gakhar L., Chappell M.C., Wohlford-Lenane C., McCray P.B., Jr. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2009;297:L84&#x2013;L96. doi: 10.1152/ajplung.00071.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00071.2009</ArticleId><ArticleId IdType="pmc">PMC2711803</ArticleId><ArticleId IdType="pubmed">19411314</ArticleId></ArticleIdList></Reference><Reference><Citation>Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O., P&#xf6;hlmann S. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein. J. Virol. 2014;88:1293&#x2013;1307. doi: 10.1128/JVI.02202-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02202-13</ArticleId><ArticleId IdType="pmc">PMC3911672</ArticleId><ArticleId IdType="pubmed">24227843</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 2016;3:237&#x2013;261. doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Chien S., Chen I., Lai C., Tsay Y., Chang S., Chang M. Surface vimentin is critical for the cell entry of SARS-CoV. J. Biomed. Sci. 2016;23:14. doi: 10.1186/s12929-016-0234-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-016-0234-7</ArticleId><ArticleId IdType="pmc">PMC4724099</ArticleId><ArticleId IdType="pubmed">26801988</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y., Tanaka N., Tanaka Y., Inoue S., Morita K., Zhuang M., Hattori T., Sugamura K. Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted. J. Virol. 2007;81:8722&#x2013;8729. doi: 10.1128/JVI.00253-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00253-07</ArticleId><ArticleId IdType="pmc">PMC1951348</ArticleId><ArticleId IdType="pubmed">17522231</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes K.V., Dveksler G., Gagneten S., Yeager C., Lin S.H., Beauchemin N., Look A.T., Ashmun R., Dieffenbach C. Coronavirus receptor specificity. Adv. Exp. Med. Biol. 1993;342:261&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209740</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard I., Limonta D., Mahal L.K., Hobman T.C. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses. 2020;13:29. doi: 10.3390/v13010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010029</ArticleId><ArticleId IdType="pmc">PMC7823949</ArticleId><ArticleId IdType="pubmed">33375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi F., Avtaar Singh S.S. Endothelial Dysfunction in SARS-CoV-2 Infection. Biomedicines. 2022;10:654. doi: 10.3390/biomedicines10030654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030654</ArticleId><ArticleId IdType="pmc">PMC8945463</ArticleId><ArticleId IdType="pubmed">35327455</ArticleId></ArticleIdList></Reference><Reference><Citation>Meher M., Pradhan S., Pradhan S.R. Risk Factors Associated with Hypertension in Young Adults: A Systematic Review. Cureus. 2023;15:e37467. doi: 10.7759/cureus.37467.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.37467</ArticleId><ArticleId IdType="pmc">PMC10181897</ArticleId><ArticleId IdType="pubmed">37187665</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe9;nat J.M., Blais-Rochette C., Kokou-Kpolou C.K., Noorishad P.-G., Mukunzi J.N., McIntee S.-E., Dalexis R.D., Goulet M.-A., Labelle P.R. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2021;295:113599. doi: 10.1016/j.psychres.2020.113599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113599</ArticleId><ArticleId IdType="pmc">PMC7689353</ArticleId><ArticleId IdType="pubmed">33285346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczy&#x144;ska A., Gaciong Z. Przewodnik Lekarza/Guide for GPs. Termedia; Pozna&#x144;, Poland: 2008. Mental stress and hypertension; pp. 62&#x2013;67.</Citation></Reference><Reference><Citation>Deng H.-B., Tam T., Zee B.C.-Y., Chung R.Y.-N., Su X., Jin L., Chan T.-C., Chang L.-Y., Yeoh E.-K., Lao X.Q. Short Sleep Duration Increases Metabolic Impact in Healthy Adults: A Population-Based Cohort Study. Sleep. 2017;40:zsx130. doi: 10.1093/sleep/zsx130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsx130</ArticleId><ArticleId IdType="pubmed">28977563</ArticleId></ArticleIdList></Reference><Reference><Citation>Albikawi Z.F. Fear Related to COVID-19, Mental Health Issues, and Predictors of Insomnia among Female Nursing College Students during the Pandemic. Healthcare. 2023;11:174. doi: 10.3390/healthcare11020174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11020174</ArticleId><ArticleId IdType="pmc">PMC9859541</ArticleId><ArticleId IdType="pubmed">36673542</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles-Cabrera A., Michel-Ch&#xe1;vez A., Callejas-Rojas R.C., Malamud-Kessler C., Delgado G., Esta&#xf1;ol-Vidal B. The cardiovagal, cardiosympathetic and vasosympathetic arterial baroreflexes and the neural control of short-term blood pressure. Rev. Neurol. 2014;59:508&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">25418146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchheim H.R. Systemic arterial baroreceptor reflexes. Physiol. Rev. 1976;56:100&#x2013;177. doi: 10.1152/physrev.1976.56.1.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1976.56.1.100</ArticleId><ArticleId IdType="pubmed">174143</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19-associated vasculitis and vasculopathy. J. Thromb. Thrombolysis. 2020;50:499&#x2013;511. doi: 10.1007/s11239-020-02230-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02230-4</ArticleId><ArticleId IdType="pmc">PMC7373848</ArticleId><ArticleId IdType="pubmed">32700024</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Bilato C., Pasquetto G., Mazza A. Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis. High. Blood Press. Cardiovasc. Prev. 2023;30:227&#x2013;233. doi: 10.1007/s40292-023-00574-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-023-00574-5</ArticleId><ArticleId IdType="pmc">PMC10105348</ArticleId><ArticleId IdType="pubmed">37060396</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeghy R.E., Province V.M., Stute N.L., Augenreich M.A., Koontz L.K., Stickford J.L., Stickford A.S.L., Ratchford S.M. Carotid stiffness, intima-media thickness and aortic augmentation index among adults with SARS-CoV-2. Exp. Physiol. 2022;107:694&#x2013;707. doi: 10.1113/EP089481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089481</ArticleId><ArticleId IdType="pmc">PMC8239784</ArticleId><ArticleId IdType="pubmed">33904234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gathiram P., Mackraj I., Moodley J. The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: A Review. Curr. Hypertens. Rep. 2021;23:17. doi: 10.1007/s11906-021-01134-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-021-01134-9</ArticleId><ArticleId IdType="pmc">PMC7993901</ArticleId><ArticleId IdType="pubmed">33768439</ArticleId></ArticleIdList></Reference><Reference><Citation>NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957&#x2013;980. doi: 10.1016/S0140-6736(21)01330-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01330-1</ArticleId><ArticleId IdType="pmc">PMC8446938</ArticleId><ArticleId IdType="pubmed">34450083</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan A.S., Coronado F., Casper M., Loustalot F., Wright J.S. County-Level Trends in Hypertension-Related Cardiovascular Disease Mortality-United States, 2000 to 2019. J. Am. Heart Assoc. 2022;11:e024785. doi: 10.1161/JAHA.121.024785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.024785</ArticleId><ArticleId IdType="pmc">PMC9075476</ArticleId><ArticleId IdType="pubmed">35301870</ArticleId></ArticleIdList></Reference><Reference><Citation>Wytyczne Polskiego Towarzystwa Nadci&#x15b;nie Polsce, Rules for the management of hypertension. Arter. Hypertens. 2008;12:317&#x2013;342.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>